First Horizon Pharmaceuticals’ Cognex (correction)
Executive Summary
First Horizon owns Alzheimer's disease agent Cognex; company purchased rights from Warner-Lambert in 2000 ahead of the Pfizer merger (1"The Pink Sheet" June 26, 2000, p. 20). "The Pink Sheet" incorrectly reported the product as a Pfizer drug in the Oct. 20 issue...